METTL3 and laryngotracheoesophageal cleft: In-depth studies have revealed that METTL3 strengthened the expression of SLC7A11, which is a crucial negative regulator of ferroptosis, by means of its N6-methyladenosine (m6A) activity in hepatoblastoma and LC.